Per Eystein Lønning
Short Curriculum Vitae for Professor Per Eystein Lønning
Principal investigator for the Breast Cancer Group
Email per.eystein.lonning@helse-bergen.no
Phone +47 55972010
Address Jonas Lies vei 65, 5021 Bergen, Norway
Positions Professor at Section for Oncology,
Institute of Medicine, University
of Bergen
Consultant at Department of Oncology,
Haukeland University Hospital
Academic degrees and employment
*1979 Graduated (MD), University of Bergen,
Norway
*1988 Certified as specialist in Therapeutic Oncology and Radiotherapy
*1989 PhD (Dissertation)
*1990 Consultant at the department of Oncology,
Haukeland University Hospital
*1992 Appointed as professor at the University of Bergen
*1998 Main Position as professor at the same University
Research
His major topic in scientific research was initially on endocrine treatment of breast cancer, with particular emphasis on translational research exploring the mechanism of action and resistance toward endocrine therapy with aromatase inhibitors. His research activity also involved pharmacology and pharmacokinetics of different agents used in breast cancer. Currently, the main focus is on genetic factors causing resistance toward chemotherapy and genetic and epigenetic factors related to risk of developing breast as well as gynecological cancers.
*About 300 papers in journals with referee-service
* > 19.000 citations ISI Web of Science ;h-score = 48
*Supervision of PhD candidates leading to a dissertation: 2001-2010: n = 7
Rewards
*1999 Olav V Norwegian National Prize in Cancer Research granted by the
Norwegian Cancer Society
*2004 Western Norway health region: “Scientist of the Year”
*2010- Member of the Norwegian Academy of Science and Letters
(Det Norske Videnskapsakademi)
Administrative experience:
*1989 Member of the Steering Comitte, Norwegian Breast Cancer Group
*1993-> Member of the Board, Norwegian Breast Cancer Group
*1994-1998 Member of the Steering Committee,
Scandinavian Breast Cancer Group
*1993-2001 Member of the General Council, Norwegian Cancer Society
*1999-2005 Co-Director Hospital Program on Gene Therapy
*1998-2003 Member of evaluation committee for translational research
The Norwegian cancer Society
*2004-2005 Chairman, evaluation committee for translational research,
The Norwegian cancer Society
*2006-2007 Chairman, evaluation committee for clinical research,
The Norwegian Cancer Society
*2008 Co-Chairman, Centra Committee for Research Grant Application,
The Norwegian Cancer Society
*2010-> Co-Chairman, Centra Committee for Research Grant Application,
The Norwegian Cancer Society
Publications
Follow link to PubMed
Sist endret: 4.12.2012
- Translasjonell forskning
- Kreft